domenica, 24 ottobre 2021
17 Giugno 2016

Metastatic Pancreatic Cancer

To provide evidence-based recommendations to oncologists and others for the treatment of patients with metastatic pancreatic cancer. ASCO convened an expert panel of medical oncology, radiation oncology, surgical oncology, gastroenterology, palliative care, and advocacy experts to conduct a systematic review of the literature from April 2004 to June 2015. Outcomes were overall survival, disease-free survival, progression-free survival, and adverse events. Twenty-four randomized controlled trials met the systematic review criteria. A multiphase computed tomography scan of the chest, abdomen, and … (leggi tutto)